Dolphin Medical Services Ltd.

2.67 ▼0%

26 March 2024, 04:00:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.dolphinmedicalservices.com
Market Cap 4.03 Cr.
Enterprise Value(EV) 4.77 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.04 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 66.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 6.76 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.40 Calculated using Price: 2.67
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.51 Cr. 15,099,952 Shares
FaceValue 10
About Dolphin Medical Services Ltd.
Dolphin Medical Services Ltd. is an organization promoted by the doctors of the region. The chief promoters are Dr. M S S Koteswara Rao, an eminent physician and former Minister for health in Andhra Pradesh and Dr. G V Mohan Prasad, a radiologist cum ENT specialist who is also the Managing Director of the company. Dolphin was founded with a lofty ideal of providing quality medical services to improve the quality of life of the people through better health, in the last decade of the the 20th century by renowned medical technologists.

Dolphin Medical Services Ltd. Delivery

Delivered Qty
Traded Qty

Dolphin Medical Services Ltd. Performance

1 Day
1 Week
-4.98%
1 Month
-10.40%
3 Month
+36.22%
6 Month
+44.32%
1 Year
+70.06%
2 Year
+27.75%
5 Year
+210.47%
10 Year
+130.17%

Dolphin Medical Services Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -4.39 -0.36 -2.12 -2.41 -8.6 -3.5 -2.93 -1.8 -1.22
Return on Capital Employed (%) -2.56 -0.06 -1.43 -1.57 -5.38 -2.07 -2.01 -1.5 -0.98
Return on Assets (%) -2.62 -0.21 -1.25 -1.41 -5.15 -2.15 -2.07 -1.53 -1.02

Dolphin Medical Services Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 13 13 12 12 11 11 10 10 10 10
Non Curr. Liab. 9 9 9 9 7 7 1 1 1 1
Curr. Liab. 0 0 0 0 0 0 1 1 1 1
Minority Int.
Equity & Liab. 22 22 21 21 18 18 12 12 12 12
Non Curr. Assets 20 20 19 19 16 16 10 10 10 10
Curr. Assets 2 2 2 2 2 2 2 2 2 2
Misc. Exp. not W/O
Total Assets 22 22 21 21 18 18 12 12 12 12

Dolphin Medical Services Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 0 1 0 0 0 0 0 1 1 1
Other Income 0 0 0 0 0 0 6 0 0 0
Total Income 0 1 0 0 0 0 6 1 1 1
Total Expenditure 0 0 0 0 -1 -1 -6 -1 -1 -1
PBIDT 0 0 0 0 -1 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT -1 0 0 0 -1 0 0 0 0 0
Adjusted EPS 0 0 0 0 -1 0 0 0 0 0

Dolphin Medical Services Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 0 2 0
Cash Fr. Finan. 0 0 0 0 -2 0 0 0 0
Net Change 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Dolphin Medical Services Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 26.44 26.44 26.44 26.44 26.44 26.44 26.44 26.44 26.44
Public 73.56 73.56 73.56 73.56 73.56 73.56 73.56 73.56 73.56
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Dolphin Medical Services Ltd. Announcements

Thu, 28 Mar 2024
Closure of Trading Window
Closure of Trading Window
Wed, 14 Feb 2024
Unaudited Financial Results For The Quarter Ended 31.12.2023
Unaudited Financial Results for the Quarter ended 31.12.2023
Sat, 03 Feb 2024
Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For The Quarter Ended 31.12.2023
DOLPHIN MEDICAL SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve unaudited financial results for the Quarter ended 31.12.2023

Dolphin Medical Services Ltd. Technical Scans

Tue, 26 Mar 2024
Close Crossing Last Week Low Close Crossing Last Week Low
Opening at High Opening at High
Opening at Low Opening at Low
Closing Below Previous Low Closing Below Previous Low
Close Below Last Week Low Close Below Last Week Low

Dolphin Medical Services Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Dolphin Medical Services Ltd. FAQ's

What is Dolphin Medical Serv share price?

Can I buy Dolphin Medical Serv shares now?

What is the Market Cap of Dolphin Medical Serv?

What are the key metrics to analyse Dolphin Medical Serv?

What is the 52 Week High and Low of Dolphin Medical Serv?